News Column

Tasly to Issue CNY1.2bn Shares to Majority Shareholder

June 18, 2014

GUANGDONG, June 18, SinoCast -- Tasly Pharmaceutical Group intended to raise not less than CNY 1.2 billion and not more than CNY 2.5 billion from six companies, all of which are controlled by the former's actual controller Yan Xijun.

This means an additional share purchase by the majority shareholder and the shares to be subscribed this time shall not be transferred within 36 months since the end of this issuance.

The move is expected to help Tasly to increase circulating assets of CNY 1.2 billion, reduce assets-liability ratio to 55.13%, lift liquidity ratio to 1.37, improve the financial condition and significantly improve the risk resisting ability.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Sinocast Health Care & Medicine Beat (China)

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters